Pulse Biosciences, Inc.
Pulse Biosciences, Inc. (PLSE) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
plse · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Pulse Biosciences, Inc. (PLSE) measures how much investors pay for each dollar of the company's trailing earnings. PLSE's current PE ratio of N/A is calculated by dividing its stock price of $25.52 by its TTM earnings per share of -$1.10.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2014 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Medical - Instruments & Supplies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Pulse Biosciences, Inc.You PLSE | $1.8B | N/A | — | -$1.10 |
 Atai Beckley Inc. ATAI | $1.4B | N/A | — | -$2.91 |
 Beta Bionics, Inc. BBNX | $634M | N/A | — | -$1.81 |
 Dianthus Therapeutics, Inc. DNTH | $3.4B | N/A | — | -$4.30 |
 Immatics N.V. IMTX | $1.3B | N/A | — | -$1.61 |
 Kestra Medical Technologies, Ltd. KMTS | $1.2B | N/A | — | -$2.30 |
 LifeMD, Inc. LFMD | $237M | N/A | — | -$0.16 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.08 | — | |
2024-12-31 FY2024 | — | $-0.92 | — | |
2023-12-31 FY2023 | — | $-0.88 | — | |
2022-12-31 FY2022 | — | $-1.72 | — | |
2021-12-31 FY2021 | — | $-2.28 | — | |
2020-12-31 FY2020 | — | $-2.14 | — | |
2019-12-31 FY2019 | — | $-2.22 | — | |
2018-12-31 FY2018 | — | $-2.20 | — | |
2017-12-31 FY2017 | — | $-1.73 | — | |
2016-12-31 FY2016 | — | $-0.86 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Pulse Biosciences, Inc. (PLSE) measures how much investors pay for each dollar of the company's trailing earnings. PLSE's current PE ratio of N/A is calculated by dividing its stock price of $25.52 by its TTM earnings per share of -$1.10.
Frequently asked questions
PLSE pe ratio · 6 questionsPLSE's current PE ratio is N/A as of 2026-06-08, based on a stock price of $25.52 and TTM EPS of -$1.10. Data sourced from Financial Modeling Prep via PLSE's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Pulse Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-08